Mpox smuggling case prompts congressional scrutiny of National Institutes of Health

The House committee on energy and commerce is delving into the National Institutes of Health's practices after two of its scientists were charged with smuggling mpox samples and deceiving investigators. The case highlights potential lapses in biosecurity protocols and raises concerns about regulatory oversight. This situation is crucial because it underscores the need for stringent controls over high-risk pathogens, emphasizing the broader implications for public health and national security. The investigation could lead to reforms to prevent future incidents and ensure transparency in scientific research.